The time to invest is now: fighting malaria in the Sahel

For the 25 million children who live across the Sahel, where there is a seasonal surge in malaria incidence, the World Health Organization recommends seasonal malaria chemoprevention (SMC) as an effective tool in the fight against malaria. Approximately 12 million children were protected through SMC programmes in 2016, with over 6.4 million children covered through the ACCESS-SMC project, funded by UNITAID and led by Malaria Consortium in partnership with Catholic Relief Services.

For less than $5 one child is protected with SMC each year. To support our continued efforts as a GiveWell Top Charity protecting all 25 million children in the Sahel from malaria visit http://www.givewell.org/charities/malaria-consortium.

Many children will still miss out on receiving SMC in due to lack of funding and production capacity for quality assured medicines used in SMC (SP+AQ). With children in sub-Saharan Africa 14 times more likely to die before the age of five than those living elsewhere in the world, it is time to do more. Malaria can be prevented- in the Sahel, SMC can play a crucial role.

Country: The Gambia | Guinea | Chad | Burkina Faso | Nigeria | Niger | Mali

Related content